Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice.

Alhareth DY, Alanazi A, Alanazi WA, Ansari MA, Nagi MN, Ahmad SF, Attia MSM, Nadeem A, Bakheet SA, Attia SM

Open source

DOI
10.3390/biomedicines11113098
Published
2023 Nov 20
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines11113098,
  title = {Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice.},
  author = {Alhareth DY and Alanazi A and Alanazi WA and Ansari MA and Nagi MN and Ahmad SF and Attia MSM and Nadeem A and Bakheet SA and Attia SM},
  year = {2023},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines11113098},
  url = {https://doi.org/10.3390/biomedicines11113098}
}

RIS

TY  - JOUR
TI  - Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice.
AU  - Alhareth DY
AU  - Alanazi A
AU  - Alanazi WA
AU  - Ansari MA
AU  - Nagi MN
AU  - Ahmad SF
AU  - Attia MSM
AU  - Nadeem A
AU  - Bakheet SA
AU  - Attia SM
PY  - 2023
JO  - Biomedicines
DO  - 10.3390/biomedicines11113098
UR  - https://doi.org/10.3390/biomedicines11113098
ER  - 

APA

DY, A., A, A., WA, A., MA, A., MN, N., SF, A., MSM, A., A, N., SA, B., & SM, A. (2023). Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice.. Biomedicines. https://doi.org/10.3390/biomedicines11113098

Source records